Literature DB >> 29854190

Detection of Adverse Drug Reactions using Medical Named Entities on Twitter.

Andrew MacKinlay1, Hafsah Aamer1, Antonio Jimeno Yepes1.   

Abstract

Adverse Drug Reactions (ADRs) are unintentional reactions caused by a drug or combination of drugs taken by a patient. The current ADR reporting systems inevitably have delays in reporting such events. The broad scope of social media conversations on sites such as Twitter means that inevitably health-related topics will be covered. This means that these sites could then be used to detect potentially novel ADRs with less latency for subsequent further investigation. In this work, we investigate ADR surveillance using a large corpus of Twitter data, containing around 50 billion tweets spanning 3 years (2012-2014), and evaluate against over 3000 drugs reported in the FAERS database. This is both a larger corpus and broader selection of drugs than previous work in the domain. We compare the ADRs identified using our method to the FDA Adverse Event Reporting System (FAERS) database of ADRs reported using more traditional techniques, and find that Twitter is a useful resource for ADR detection up to 72% micro-averaged precision. Micro-averaged recall of 6% is achievable using only 10% of Twitter, indicating that with a higher-volume or targeted feed it would be possible to detect a large percentage of ADRs.

Entities:  

Mesh:

Year:  2018        PMID: 29854190      PMCID: PMC5977585     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  15 in total

1.  The Unified Medical Language System (UMLS): integrating biomedical terminology.

Authors:  Olivier Bodenreider
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Identifying Diseases, Drugs, and Symptoms in Twitter.

Authors:  Antonio Jimeno-Yepes; Andrew MacKinlay; Bo Han; Qiang Chen
Journal:  Stud Health Technol Inform       Date:  2015

3.  Social Media Listening for Routine Post-Marketing Safety Surveillance.

Authors:  Gregory E Powell; Harry A Seifert; Tjark Reblin; Phil J Burstein; James Blowers; J Alan Menius; Jeffery L Painter; Michele Thomas; Carrie E Pierce; Harold W Rodriguez; John S Brownstein; Clark C Freifeld; Heidi G Bell; Nabarun Dasgupta
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

Review 4.  Utilizing social media data for pharmacovigilance: A review.

Authors:  Abeed Sarker; Rachel Ginn; Azadeh Nikfarjam; Karen O'Connor; Karen Smith; Swetha Jayaraman; Tejaswi Upadhaya; Graciela Gonzalez
Journal:  J Biomed Inform       Date:  2015-02-23       Impact factor: 6.317

5.  Portable automatic text classification for adverse drug reaction detection via multi-corpus training.

Authors:  Abeed Sarker; Graciela Gonzalez
Journal:  J Biomed Inform       Date:  2014-11-08       Impact factor: 6.317

6.  Adverse drug reaction deaths reported in United States vital statistics, 1999-2006.

Authors:  Greene Shepherd; Philip Mohorn; Kristina Yacoub; Dianne Williams May
Journal:  Ann Pharmacother       Date:  2012-01-17       Impact factor: 3.154

Review 7.  Social media and pharmacovigilance: A review of the opportunities and challenges.

Authors:  Richard Sloane; Orod Osanlou; David Lewis; Danushka Bollegala; Simon Maskell; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2015-09-02       Impact factor: 4.335

Review 8.  Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.

Authors:  Jérémy Lardon; Redhouane Abdellaoui; Florelle Bellet; Hadyl Asfari; Julien Souvignet; Nathalie Texier; Marie-Christine Jaulent; Marie-Noëlle Beyens; Anita Burgun; Cédric Bousquet
Journal:  J Med Internet Res       Date:  2015-07-10       Impact factor: 5.428

9.  Postmarket drug surveillance without trial costs: discovery of adverse drug reactions through large-scale analysis of web search queries.

Authors:  Elad Yom-Tov; Evgeniy Gabrilovich
Journal:  J Med Internet Res       Date:  2013-06-18       Impact factor: 5.428

10.  Digital drug safety surveillance: monitoring pharmaceutical products in twitter.

Authors:  Clark C Freifeld; John S Brownstein; Christopher M Menone; Wenjie Bao; Ross Filice; Taha Kass-Hout; Nabarun Dasgupta
Journal:  Drug Saf       Date:  2014-05       Impact factor: 5.606

View more
  5 in total

1.  Leveraging digital media data for pharmacovigilance.

Authors:  Hammad Farooq; Junaid Suhail Niaz; Saira Fakhar; Hammad Naveed
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

2.  A Disease Identification Algorithm for Medical Crowdfunding Campaigns: Validation Study.

Authors:  Steven S Doerstling; Dennis Akrobetu; Matthew M Engelhard; Felicia Chen; Peter A Ubel
Journal:  J Med Internet Res       Date:  2022-06-21       Impact factor: 7.076

3.  Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.

Authors:  Ying Li; Antonio Jimeno Yepes; Cao Xiao
Journal:  Drug Saf       Date:  2020-09       Impact factor: 5.606

4.  Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.

Authors:  Zeyun Zhou; Kyle Emerson Hultgren
Journal:  JMIR Public Health Surveill       Date:  2020-09-30

5.  Identifying Electronic Nicotine Delivery System Brands and Flavors on Instagram: Natural Language Processing Analysis.

Authors:  Rob Chew; Michael Wenger; Jamie Guillory; James Nonnemaker; Annice Kim
Journal:  J Med Internet Res       Date:  2022-01-18       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.